SELL Coforge Limited — Manas Jaiswal
byManas JaiswalHorizon: 1–3 months13 Apr 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Coforge Secures All Regulatory Approvals for $2.5B Encora Acquisition Deal
NewsGoogle News·13 Apr · 2d ago
6 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·6 Apr · 1w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Coforge
- BUY — Shivangi Sarda, Motilal Oswal23 Oct 2026 · ~3 months · target ₹2,020 · Active
- SELL — Prakash Gaba22 Oct 2026 · ~2 weeks · target ₹1,870 · SL hit
- BUY — Somil Mehta, Sharekhan22 Oct 2026 · ~1 year · target ₹2,200 · Active
- BUY — Manas Jaiswal22 Oct 2026 · Same day · target ₹2,010 · SL hit
- BUY — Sumeet Bagadia, Choice Broking22 Oct 2026 · Same day · target ₹1,980 · Target hit
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

